Cytokinetics Inc: EVP Malik Fady Ibraham sold 3,500 shares

What happened Malik Fady Ibraham, EVP research & development, exercised options and sold shares. The filing reports exercise of 3,500 shares at $7.80 each for $27,300, an open-market sale of 3,500 shares at $64.01 each for $224,035, and a reported derivative conversion/disposal of 3,500 shares at $0.00 for $0.

Key details

• Transaction dates and prices: Oct 20, 2026 — exercised 3,500 shares at $7.80 (acquired $27,300); sold 3,500 shares at $64.01 (disposed $224,035); derivative conversion/disposal 3,500 shares at $0.00 ($0).
• Shares owned after the transaction: not reported in this filing.
• Footnotes or plans: the filing does not include footnotes, a 10b5-1 plan, or tax withholding notation.
• Filing date and timeliness: filing date Oct 20, 2026; the filing does not indicate it was late.

Why it may matter The filing shows options were exercised and that the exercised shares were sold on the same date. This filing does not show why the insider traded or why the company acted.